Trial Profile
Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Travelling Across Multiple Time Zones. A Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jun 2022
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SafrTravlT1D
- 29 Oct 2021 Results assessing glycemic control on insulin degludec versus glargine U100 as the basal insulin for adults using multiple daily injections (MDI) while traveling across multiple time zones published in the Diabetes Care
- 17 Mar 2021 Status changed from recruiting to completed.
- 16 Jun 2020 Results (n=21) assessing the sleep quality for adults with Type 1 Diabetes using multiple daily injections (MDI) of insulin flying across multiple time zones, were presented at the 80th Annual Scientific Sessions of the American Diabetes Association.